1 BTC
=
- USD
Cibus, Inc. Class A Common Stock
As of May 30, 2026 at 24:05 UTC
Chart
About Cibus, Inc. Class A Common Stock
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Market Statistics
Trading Metrics
How to Buy CBUS
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy CBUS
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesCibus, Inc. has successfully transferred gene-edited herbicide tolerance traits in rice to its partner Interoc, marking a strategic milestone toward commercializing enhanced seed products in the Latin American market. The achievement demonstrates Cibus' ability to deliver traits on schedule using its Rapid Trait Development System, with expectations for additional gene-edited materials to be delivered to partners in the coming year as regulatory frameworks for gene editing continue to harmonize globally.
Cibus, Inc. has been selected as a key technology partner in a UK Government-funded research project to develop oilseed rape varieties with resistance to Light Leaf Spot disease, which has caused estimated yield losses of £300 million. The LLS-ERASED project will utilize Cibus' proprietary Rapid Trait Development System to create durable, multi-disease resistant varieties, involving 12 industry and academic partners including the John Innes Centre and University of Hertfordshire.
Cibus, Inc., a leading agricultural biotechnology company, announced the closing of a $27.5 million public offering to fund further development of its weed management productivity traits in Rice and for working capital and general corporate purposes.
Cibus, a leading agricultural biotechnology company, announced that its Co-Founder, President, and Interim CEO participated in the BofA Securities 2025 AgTech Virtual Conference. The company discussed its gene editing platform, productivity trait pipeline, and recent regulatory developments supporting agricultural innovation.